Related references
Note: Only part of the references are listed.Epidemiology of cardiovascular disease in Europe
Nick Townsend et al.
NATURE REVIEWS CARDIOLOGY (2022)
Synthetic high-density lipoproteins delivering liver X receptor agonist prevent atherogenesis by enhancing reverse cholesterol transport
Wenmin Yuan et al.
JOURNAL OF CONTROLLED RELEASE (2021)
Poly-β-cyclodextrin Supramolecular Nanoassembly with a pH-Sensitive Switch Removing Lysosomal Cholesterol Crystals for Antiatherosclerosis
Yan Zhang et al.
NANO LETTERS (2021)
The changing landscape of atherosclerosis
Peter Libby
NATURE (2021)
Affinity-Driven Design of Cargo-Switching Nanoparticles to Leverage a Cholesterol-Rich Microenvironment for Atherosclerosis Therapy
Heegon Kim et al.
ACS NANO (2020)
Complement Receptor Targeted Liposomes Encapsulating the Liver X Receptor Agonist GW3965 Accumulate in and Stabilize Atherosclerotic Plaques
Naomi Benne et al.
ADVANCED HEALTHCARE MATERIALS (2020)
Cholesterol Efflux Efficiency of Reconstituted HDL Is Affected by Nanoparticle Lipid Composition
Shifa Jebari-Benslaiman et al.
BIOMEDICINES (2020)
Synergetic Effect of rHDL and LXR Agonist on Reduction of Atherosclerosis in Mice
Emily E. Morin et al.
FRONTIERS IN PHARMACOLOGY (2020)
Nanoparticle-Based Approaches towards the Treatment of Atherosclerosis
Artur Y. Prilepskii et al.
PHARMACEUTICS (2020)
Nanoparticle-based Two-pronged approach to regress atherosclerosis by simultaneous modulation of cholesterol influx and efflux
Hongliang He et al.
BIOMATERIALS (2020)
Atherosclerosis
Peter Libby et al.
NATURE REVIEWS DISEASE PRIMERS (2019)
Multifunctional Block Copolymers for Simultaneous Solubilization of Poorly Water-Soluble Cholesterol and Hydroxyapatite Crystals
Philipp Keckeis et al.
ADVANCED FUNCTIONAL MATERIALS (2019)
Recent Advances in Managing Atherosclerosis via Nanomedicine
Cecilia Ka Wing Chan et al.
SMALL (2018)
Development of mannose functionalized dendrimeric nanoparticles for targeted delivery to macrophages: use of this platform to modulate atherosclerosis
Hongliang He et al.
TRANSLATIONAL RESEARCH (2018)
Synthetic High-Density Lipoprotein-Mediated Targeted Delivery of Liver X Receptors Agonist Promotes Atherosclerosis Regression
Yanhong Guo et al.
EBIOMEDICINE (2018)
Global, Regional, and National Burden of Cardiovascular Diseases for 10 Causes, 1990 to 2015
Gregory A. Roth et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2017)
Clinical efficacy and safety of achieving very low LDL-cholesterol concentrations with the PCSK9 inhibitor evolocumab: a prespecified secondary analysis of the FOURIER trial
Robert P. Giugliano et al.
LANCET (2017)
Hyaluronan Nanoparticles Selectively Target Plaque-Associated Macrophages and Improve Plaque Stability in Atherosclerosis
Thijs J. Beldman et al.
ACS NANO (2017)
Cyclodextrin promotes atherosclerosis regression via macrophage reprogramming
Sebastian Zimmer et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
A Century of Cholesterol and Coronaries: From Plaques to Genes to Statins
Joseph L. Goldstein et al.
CELL (2015)
Functional block copolymer assemblies responsive to tumor and intracellular microenvironments for site-specific drug delivery and enhanced imaging performance
Zhishen Ge et al.
CHEMICAL SOCIETY REVIEWS (2013)
Nanomedicine for the prevention, treatment and imaging of atherosclerosis
Costas Psarros et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2012)
Endosomal escape pathways for delivery of biologicals
Amir K. Varkouhi et al.
JOURNAL OF CONTROLLED RELEASE (2011)
Atherosclerosis: current pathogenesis and therapeutic options
Christian Weber et al.
NATURE MEDICINE (2011)
Cholesterol Efflux Capacity, High-Density Lipoprotein Function, and Atherosclerosis
Amit V. Khera et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials
C. Baigent et al.
LANCET (2010)
Association between change in high density lipoprotein cholesterol and cardiovascular disease morbidity and mortality: systematic review and meta-regression analysis
Matthias Briel et al.
BMJ-BRITISH MEDICAL JOURNAL (2009)
The Cl-/H+ antiporter ClC-7 is the primary chloride permeation pathway in lysosomes
Austin R. Graves et al.
NATURE (2008)
Effects of aggressive versus conventional lipid-lowering therapy by simvastatin on human atherosclerotic lesions - A prospective, randomized, double-blind trial with high-resolution magnetic resonance imaging
R Corti et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2005)
Mechanisms of disease - Inflammation, atherosclerosis, and coronary artery disease
GK Hansson
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Stimulation of lipogenesis by pharmacological activation of the liver X receptor leads to production of large, triglyceride-rich very low density lipoprotein particles
A Grefhorst et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Share Paper
